© Copyright GW Pharmaceuticals 2020
This website is intended for healthcare professionals only. If you are not a healthcare professional, please visit www.gwpharm.co.uk
Date of Preparation: December 2020
For more information about Epidyolex® (cannabidiol), please refer to the Epidyolex® summary of product characteristics and/or the Epidyolex® website for UK Healthcare Professionals.
Click on the link below to access the country-specific prescribing information for the UK.
For more information about GW Pharmaceuticals, please visit our corporate website.
Adverse events should be reported according to local regulations. For the UK, reporting forms and information can be found on the MHRA yellow card site at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to GW pharma on firstname.lastname@example.org.